• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares (NQ:KNSA)

41.06 -0.95 (-2.26%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 699,948
Open 41.82
Bid (Size) 41.05 (200)
Ask (Size) 41.12 (100)
Prev. Close 42.01
Today's Range 39.16 - 41.91
52wk Range 17.82 - 44.42
Shares Outstanding 71,726,685
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the High-Growth Momentum and Trend Template Strategy ↗
December 13, 2025
KNSA stock meets Minervini's Trend Template with strong technicals and high-growth fundamentals, including surging EPS and revenue. 
Via Chartmill
News headline image
Kiniksa (KNSA) Q3 2025 Earnings Call Transcript ↗
November 27, 2025
Kiniksa (KNSA) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
-2.2%
-2.2%
1 Month
-1.5%
-1.5%
3 Month
+7.2%
+7.2%
6 Month
+46.9%
+46.9%
1 Year
+105.1%
+105.1%

More News

Read More
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Combines Technical Strength and Fundamental Growth Momentum ↗
November 20, 2025
Via Chartmill
News headline image
Earnings Scheduled For October 28, 2025 ↗
October 28, 2025
Via Benzinga
News headline image
What to Expect from Kiniksa Pharmaceuticals's Earnings ↗
October 27, 2025
Via Benzinga
News headline image
5 Analysts Have This To Say About Kiniksa Pharmaceuticals ↗
October 17, 2025
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2025 ↗
July 29, 2025
Via Benzinga
News headline image
Earnings Preview: Kiniksa Pharmaceuticals ↗
July 28, 2025
Via Benzinga
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Identified by High Growth Momentum and Minervini Trend Screen ↗
October 08, 2025
Via Chartmill
News headline image
What Analysts Are Saying About Kiniksa Pharmaceuticals Stock ↗
September 29, 2025
Via Benzinga
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗
September 24, 2025
Via Chartmill
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Emerges as an Affordable Growth Opportunity ↗
September 22, 2025
Via Chartmill
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top Affordable Growth Candidate ↗
September 01, 2025
Via Chartmill
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential ↗
August 25, 2025
Via Chartmill
News headline image
KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout ↗
August 22, 2025
Via Chartmill
News headline image
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) – An Affordable Growth Stock with Strong Fundamentals and Fair Valuation ↗
August 08, 2025
Via Chartmill
News headline image
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Aligns with Minervini’s Trend Model as a Strong Momentum Pick ↗
August 05, 2025
Via Chartmill
News headline image
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗
August 04, 2025
Via Benzinga
News headline image
Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter? ↗
August 04, 2025
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
July 25, 2025
Via Benzinga
News headline image
Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth ↗
July 02, 2025
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
May 05, 2025
Via Benzinga
News headline image
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗
May 04, 2025
Via Benzinga
Topics Artificial Intelligence
News headline image
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
April 30, 2025
From Kiniksa Pharmaceuticals, Ltd.
Via GlobeNewswire
News headline image
These stocks are gapping in today's session ↗
April 29, 2025
Via Chartmill

Frequently Asked Questions

Is Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares publicly traded?
Yes, Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is publicly traded.
What exchange does Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trade on?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
What is the current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 41.06
When was Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares last traded?
The last trade of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares was at 01/05/26 04:00 PM ET
What is the market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 2.95B
How many shares of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares are outstanding?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap